Bank of America’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.1B | Buy |
|
|||||
2025
Q1 | $2.06B | Buy |
|
|||||
2024
Q4 | $1.64B | Buy |
|
|||||
2024
Q3 | $606M | Buy |
|
|||||
2024
Q2 | $458M | Buy |
|
|||||
2024
Q1 | $485M | Buy |
|
|||||
2023
Q4 | $524M | Buy |
|
|||||
2023
Q3 | $403M | Sell |
|
|||||
2023
Q2 | $415M | Sell |
|
|||||
2023
Q1 | $639M | Buy |
|
|||||
2022
Q4 | $651M | Buy |
|
|||||
2022
Q3 | $431M | Sell |
|
|||||
2022
Q2 | $455M | Sell |
|
|||||
2022
Q1 | $462M | Buy |
|
|||||
2021
Q4 | $509M | Sell |
|
|||||
2021
Q3 | $535M | Buy |
|
|||||
2021
Q2 | $491M | Sell |
|
|||||
2021
Q1 | $517M | Buy |
|
|||||
2020
Q4 | $311M | Sell |
|
|||||
2020
Q3 | $465M | Buy |
|
|||||
2020
Q2 | $566M | Sell |
|
|||||
2020
Q1 | $619M | Sell |
|
|||||
2019
Q4 | $552M | Buy |
|
|||||
2019
Q3 | $459M | Buy |
|
|||||
2019
Q2 | $439M | Sell |
|
|||||
2019
Q1 | $452M | Buy |
|
|||||
2018
Q4 | $433M | Sell |
|
|||||
2018
Q3 | $605M | Sell |
|
|||||
2018
Q2 | $558M | Buy |
|
|||||
2018
Q1 | $590M | Sell |
|
|||||
2017
Q4 | $561M | Sell |
|
|||||
2017
Q3 | $842M | Buy |
|
|||||
2017
Q2 | $638M | Sell |
|
|||||
2017
Q1 | $685M | Sell |
|
|||||
2016
Q4 | $750M | Sell |
|
|||||
2016
Q3 | $851M | Sell |
|
|||||
2016
Q2 | $927M | Buy |
|
|||||
2016
Q1 | $960M | Sell |
|
|||||
2015
Q4 | $1.07B | Buy |
|
|||||
2015
Q3 | $1.02B | Buy |
|
|||||
2015
Q2 | $892M | Sell |
|
|||||
2015
Q1 | $769M | Sell |
|
|||||
2014
Q4 | $987M | Sell |
|
|||||
2014
Q3 | $1.19B | Sell |
|
|||||
2014
Q2 | $1,000M | Sell |
|
|||||
2014
Q1 | $857M | Buy |
|
|||||
2013
Q4 | $838M | Buy |
|
|||||
2013
Q3 | $560M | Sell |
|
|||||
2013
Q2 | $796M | Buy |
|